A. Alonso

Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs in rheumatoid arthritis: results of the GO-MORE study in Spain.

J. Gómez-Reino, A. Fernández-Nebro, R. Sanmartí, 2015, Reumatologia clinica.

Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial

S. Marsal, P. Taylor, J. Jover, 2016, Annals of the rheumatic diseases.

Efficacy of tocilizumab monotherapy after response to combined tocilizumab and methotrexate in patients with rheumatoid arthritis: the randomised JUST-ACT study.

J. Pablos, F. Blanco, E. Martín Mola, 2019, Clinical and experimental rheumatology.

Quality Standards for Rheumatology Outpatient Clinic. The EXTRELLA Project

J. Nolla, M. P. Lozano, A. Fernández-Nebro, 2016 .

Quality standards for rheumatology outpatient clinic. The EXTRELLA project.

J. Nolla, A. Fernández-Nebro, R. García-Vicuña, 2016, Reumatologia clinica.

Pharmacoeconomic analysis of Metoject ® in the treatment of rheumatoid arthritis in Spain

J. Marenco, J. Carbonell, M. Brosa, 2010 .

Severe bout of cutaneous psoriasis in a patient with psoriasic arthritis undergoing treatment with infliximab.

A. Prada, E. Uriarte Itzazelaia, A. Alonso, 2007, Clinical and experimental rheumatology.

[Pharmacoeconomic analysis of Metoject(®) in the treatment of rheumatoid arthritis in Spain].

J. Marenco, J. del Pino-Montes, J. Carbonell, 2010, Reumatologia clinica.